dexmedetomidine (259018)

Dexmedetomidine is a potent and highly selective alpha-2 adrenergic receptor agonist. While traditionally administered intravenously for sedation in intensive care and procedural settings, Teikoku Pharma USA is developing a novel transdermal system (DMTS), also known as TPU-006, for the management of postoperative pain. This formulation is designed as a patch to provide sustained release of the drug over a period of several days (e.g., 4 days), offering a non-opioid analgesic alternative. By activating presynaptic alpha-2 receptors in the locus coeruleus and spinal cord, dexmedetomidine inhibits the release of norepinephrine, thereby modulating pain signaling and providing analgesic effects without the respiratory depression typically associated with opioids.

Other names

Dexmedetomidine Transdermal System